Citadel Advisors
AXNX

Citadel Advisors’s Axonics, Inc. Common Stock AXNX Stock Holding History

Citadel Advisors’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-170,323
Closed -$11.9M – 15692
2024
Q3 		$11.9M Buy
170,323
+148,261
+672% +$10.2M ﹤0.01% 2666
2024
Q2 		$1.48M Buy
22,062
+3,694
+20% +$249K ﹤0.01% 5858
2024
Q1 		$1.27M Sell
18,368
-66,350
-78% -$4.48M ﹤0.01% 6445
2023
Q4 		$5.27M Sell
84,718
-665,408
-89% -$37.2M ﹤0.01% 3703
2023
Q3 		$42.1M Buy
750,126
+348,006
+87% +$19.6M 0.01% 1212
2023
Q2 		$20.3M Buy
402,120
+114,833
+40% +$6.11M ﹤0.01% 1868
2023
Q1 		$15.7M Sell
287,287
-238,065
-45% -$13.9M ﹤0.01% 2211
2022
Q4 		$32.9M Buy
525,352
+186,650
+55% +$12.4M 0.01% 1473
2022
Q3 		$23.9M Buy
338,702
+13,929
+4% +$961K 0.01% 1703
2022
Q2 		$18.4M Buy
324,773
+299,886
+1,205% +$16.4M ﹤0.01% 1923
2022
Q1 		$1.56M Sell
24,887
-302,919
-92% -$16.3M ﹤0.01% 6645
2021
Q4 		$18.4M Buy
327,806
+229,711
+234% +$14M ﹤0.01% 2130
2021
Q3 		$6.38M Sell
98,095
-284,377
-74% -$19.4M ﹤0.01% 3849
2021
Q2 		$24.3M Sell
382,472
-385,767
-50% -$22.8M 0.01% 1854
2021
Q1 		$46M Buy
768,239
+639,485
+497% +$34.8M 0.01% 1108
2020
Q4 		$6.43M Buy
128,754
+70,540
+121% +$3.31M ﹤0.01% 3254
2020
Q3 		$2.97M Sell
58,214
-17,979
-24% -$751K ﹤0.01% 4004
2020
Q2 		$2.67M Sell
76,193
-79,999
-51% -$2.76M ﹤0.01% 4053
2020
Q1 		$3.97M Sell
156,192
-331,791
-68% -$9.87M ﹤0.01% 3043
2019
Q4 		$13.5M Sell
487,983
-30,869
-6% -$737K 0.01% 1886
2019
Q3 		$14M Buy
518,852
+461,538
+805% +$16.1M 0.01% 1849
2019
Q2 		$2.35M Buy
57,314
+46,612
+436% +$1.31M ﹤0.01% 4247
2019
Q1 		$257K Sell
10,702
-863
-7% -$15.7K ﹤0.01% 7846
2018
Q4 		$175K Buy
+11,565
New +$172K ﹤0.01% 7964

Other funds holding AXNX

TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Citadel Advisors's AXNX Position: Q4 2024 in Review

Citadel Advisors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 170,323 shares — an estimated $11.9M sold.

Citadel Advisors first reported a position in AXNX in Q4 2018 and held it in 24 quarters. The position peaked at $46M in Q1 2021. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Citadel Advisors reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 170,323 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $11.9M.
  • Citadel Advisors first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Citadel Advisors's Axonics, Inc. Common Stock position peaked at $46M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.